Timo Soeterik

134 CHAPTER 7 REFERENCES 1. Walsh PC. The discovery of the Cavernous Nerves and Development of Nerve Sparing Radical Retropubic Prostatectomy J Urol . 2007;177:1632-1635. 2. Nguyen LN, Head L, Witiuk K et al. The Risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: A Systematic Review and Meta-Analysis. J Urol . 2017;198:760-769. 3. Mottet N, Bellmunt J, Bolla M, et al. EAU- ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol . 2017;71:618-629. 4. Memorial Sloan Kettering Cancer Center. Pre-radical prostatectomy tool to predict probability of extraprostatic extension in prostate cancer patients. www.mskcc.org/ nomograms/prostate/pre_op. 5. Tosoian JJ, Chappidi M, Feng Z, Humphreys EB, Han M, Pavlovich CP, et al. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era. BJU Int . 2017;119:676-683. 6. Ohori M, Kattan MW, Koh H, et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol . 2004;171:1844-1849. 7. Sayyid R, Perlis N, Ahmad A, et al. Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extension. BJU Int . 2017;120:76-82. 8. Patel VR, Sandri M, Grasso AAC, et al. A novel tool for predicting extracapsular extension during graded partial nerve sparing in radical prostatectomy. BJU Int . 2018;121:373-382. 9. Caglic I, Kovac V, Barrett T. Multiparametric MRI - local staging of prostate cancer and beyond. Radiol Oncol . 2019;53:159-170. 10. de Rooij M, Hamoen EH, Witjes JA, et al. Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. Eur Urol . 2016;70:233-245. 11. Rayn KN, Bloom JB, Gold SA, et al. Added Value of Mult iparametric Magnet ic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer. J Urol . 2018;200:1041-1047. 12. Gandaglia G, Ploussard G, Valerio M, et al. The Key Combined Value of Multiparametric Magnet ic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol . 2020;77:733-741. 13. Rocco B, Sighinolfi MC, Sandri M, et al. Is Extraprostatic Extension of Cancer Predictable? A Review of Predictive Tools and an External Validation based on a Large and a Single Center Cohort of Prostate Cancer Patients. Urology . 2019;129:8-20. 14. Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol . 2012;22:746-57. 15. Weinreb JC, Barentsz JO, Choyke PL, et al. PI- RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. EurUrol . 2016;69:16-40. 16. Buyyounouski MK, Choyke PL, McKenney JK, et al. Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:245-253. 17. Baco E, Rud E, Vlatkovic L, et al. Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer. J Urol . 2015;193:466-72. 18. Cornud F, Rouanne M, Beuvon F, et al. Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D’Amico tumor risk criteria?. Eur J Radiol . 2012;81:591-597.